Compass, Inc. Share Price Target ‘$4.15’, now -4.2% Downside Potential

DirectorsTalk Interviews

Compass, Inc. which can be found using ticker (COMP) have now 9 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $6.00 and $3.00 calculating the mean target share price we have $4.15. (at the time of writing). Given that the stocks previous close was at $4.33 this would imply there is a potential downside of -4.2%. It’s also worth noting that there is a 50 day moving average of $3.56 while the 200 day moving average is $3.18. The market cap for the company is 2.13B. The stock price for Affirm Holdings, Inc. is $4.30 USD

The potential market cap would be $2,037,923,773 based on the market consensus.

The company has a dividend yield of 5.95%. Other points of data to note are a P/E ratio of -, revenue per share of $10.46 and a -10.37% return on assets.

Compass, Inc. is a technology-enabled brokerage that provides an end-to-end platform of software, services, and support to helps its residential real estate agents to deliver service to seller and buyer clients. The Company’s platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service, brokerage services and other critical functionalities, all custom-built for the real estate industry and enables its core brokerage services. The platform also uses data, analytics, artificial intelligence and machine learning to deliver recommendations and outcomes for Compass agents and their clients. Agents use its platform to assist home sellers and buyers in listing, marketing, selling and finding homes, as well as through the provision of services, such as title, escrow and mortgage. Its Glide tools include completion of various real estate forms, offers preparation, as well as e-signature and collaboration capabilities.

Share on:

Latest Company News

Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research

Drax Group signs second BESS tolling agreement as Longspur Research lifts valuation to 1093p on strengthened flexibility strategy.

Aston Martin to sell F1 naming rights for £50m; FY2025 margin at c.29.5%

Aston Martin has agreed a proposed £50m transaction to grant AMR GP perpetual rights to use its name in Formula One operations, pending shareholder approval. FY2025 wholesale volumes declined to 5,448 units, with adjusted EBIT expected slightly below the lower end of analyst forecasts, as the group looks to stronger results in 2026.

NCC Group to host cyber-focused Capital Markets Event on 13 March 2026

NCC Group plc will host a Capital Markets Event for institutional investors and analysts on Friday 13 March 2026, focused on its Cyber business and growth strategy.

Anglo American delivers steady EBITDA and advances Anglo Teck transaction in 2025

Underlying EBITDA rose to $6.4 billion in 2025 as Anglo American progressed divestments and secured key approvals for its merger with Teck.

SEGRO delivers strong FY2025 performance with record £99m new rent

For the year ended 31 December 2025, SEGRO achieved record leasing, 6.1% growth in adjusted earnings per share and a 6.0% rise in like-for-like net rental income.

AstraZeneca secures US Approval for fixed-duration Calquence regimen in CLL

AstraZeneca’s Calquence plus venetoclax has been approved in the US as the first all-oral, 14-month treatment option for adults with CLL and SLL, following Phase III data showing improved progression-free survival versus chemoimmunotherapy.

    Search

    Search